# Vaishali Pharma (NSE: VAISHALI) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/VAISHALI · Pivot · prices to 22 Oct 2026

Vaishali Pharma (NSE: VAISHALI) closed at ₹7.49 on 22 Oct 2026, up 2.04% on the day. With a market capitalisation of ₹101 Cr, it ranks 2673rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

At its last close the stock traded at 124.8× trailing earnings, against a return on equity of 1.3% in FY25. Over the past year the share price has fallen 30.3%. Its 52-week range is ₹4.75 (30 Mar 2026) to ₹11.15 (28 Oct 2025); the last close is 32.8% below the high. Promoters held 30.54% of the company as of 3 Jul 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹7.49 |
| Market cap | ₹101 Cr |
| P/E (trailing) | 124.8 |
| ROE | 1.3% (FY25) |
| ROCE | 4.0% (FY25) |
| Debt to equity | 0.18 |
| 52-week high | ₹11.15 (28 Oct 2025) |
| 52-week low | ₹4.75 (30 Mar 2026) |
| 1-year return | −30.3% |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹99 Cr | ₹1 Cr |
| FY24 | ₹86 Cr | ₹1 Cr |
| FY23 | ₹70 Cr | ₹7 Cr |
| FY22 | ₹76 Cr | ₹4 Cr |
| FY21 | ₹54 Cr | ₹1 Cr |
| FY20 | ₹60 Cr | ₹0 Cr |

## Shareholding (3 Jul 2026)

- Promoters: 30.54%
- Non-institutions: 69.46%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Mercury Labs](https://app.pivotnow.in/stock/MERCURYLAB) | — | ₹102 Cr | — | — |
| [Concord Drugs](https://app.pivotnow.in/stock/CONCORD) | — | ₹101 Cr | — | — |
| [Denis Chem Lab](https://app.pivotnow.in/stock/DENISCHEM) | — | ₹101 Cr | — | — |
| [Fortis Malar](https://app.pivotnow.in/stock/FORTISMLR) | — | ₹97 Cr | — | — |
| [Raaj Medisafe](https://app.pivotnow.in/stock/RAAJMEDI) | — | ₹97 Cr | — | — |
| [KHFM HOSPITALIT](https://app.pivotnow.in/stock/KHFM) | ₹40.90 | ₹95 Cr | — | — |

## Questions and answers

### What is the share price of Vaishali Pharma today?

Vaishali Pharma (NSE: VAISHALI) last closed at ₹7.49 on 22 Oct 2026. Its 52-week high is ₹11.15 and its 52-week low is ₹4.75.

### What is the market cap of Vaishali Pharma?

Vaishali Pharma's market capitalisation is ₹101 Cr (₹101 Cr) at the 22 Oct 2026 close, ranking 2673rd among the NSE companies Pivot tracks.

### What is the P/E ratio of Vaishali Pharma?

Vaishali Pharma trades at a trailing P/E of 124.8.

### What is the ROE and ROCE of Vaishali Pharma?

Return on equity was 1.3% in FY25 and return on capital employed was 4.0% in FY25 (standalone figures).

### Is Vaishali Pharma a debt-free company?

No. Vaishali Pharma's debt-to-equity ratio was 0.18 in FY25, with total debt of ₹4 Cr.

### How has Vaishali Pharma stock performed over the last year?

Vaishali Pharma's share price has fallen 30.3% over the past year, −5.2% over three months and −10.3% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Vaishali Pharma?

As of 3 Jul 2026: promoters 30.54%, non-institutions 69.46%.

### Who are Vaishali Pharma's competitors?

The listed Pharma & Healthcare companies closest to Vaishali Pharma by market cap are Mercury Labs, Concord Drugs, Denis Chem Lab, Fortis Malar, Raaj Medisafe and KHFM HOSPITALIT.

### Is Vaishali Pharma a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Vaishali Pharma's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on VAISHALI against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.